Prevest Denpro is a dental-materials manufacturer that started in a 200-square-foot room in Jammu in 1999 and now sells to over 90 countries from a 60,000-square-foot factory - one of the few companies in India that actually makes these products rather than repackaging someone else’s. The business was built by the Modi family and has stayed debt-free while expanding from basic consumables into digital dentistry, biomaterials, and oral-care brands, all developed through an in-house R&D lab that the government recognises as a research centre. The recurring approach is simple: make products that match multinational quality, sell them at a lower price because manufacturing costs in Jammu are lower, and keep adding categories so a dentist can fill most of their clinical needs from one catalogue.
Business segments
A single manufacturing-and-R&D engine that expresses itself through five product verticals - dental consumables, digital dentistry, endodontic systems, disinfectants, and a consumer oral-care brand - all built on the same factory, the same research lab, and the same distributor network.
1. Dental consumables: the catalogue that pays for everything else
Over 100 products across 12 clinical categories, sold through distributors in 90-plus countries, generate the core revenue that funds every newer vertical.
- One factory, one shift, plenty of room - the Jammu plant has an installed capacity of 200 metric tonnes a year but was running at only about 45% utilisation as of FY24, so the company can grow volumes without building a new factory.
- A product for almost every chairside need - the 12 categories span root-canal sealers, filling composites, cements, impression materials, whitening gels, and temporary crown materials, meaning a single sales call can cover most of a clinic’s recurring purchases.
- Regulatory approvals open doors - the company holds USFDA clearance for over 20 products, plus ISO 13485, CE, Saudi FDA, and MDSAP certifications covering the US, Canada, and Brazil, so it can sell into regulated markets that many smaller Indian competitors cannot reach.
- Export-first economics - roughly 60% of revenue comes from exports, where pricing and value addition are better than in India’s price-sensitive domestic market; Asia and Africa together account for about 70% of geographic revenue, with Europe at roughly 20%.
- Training creates loyalty - the company runs continuing-education programmes for dentists and has tie-ups with 12 dental colleges, so clinicians learn on Prevest products and tend to reorder what they know.
2. Digital dentistry: the highest-priority bet on the future
A developing ecosystem of 3D-printing resins, in-house LCD printers, and intraoral scanners that management calls its most important growth segment.
- Resins first, hardware next - the company already sells dental-grade 3D-printing resins for crowns, bridges, inlays, onlays, and veneers, and is now designing its own LCD-based 3D printers using sourced components, aiming for an integrated printer-plus-resin system.
- Chasing a fast-growing market - the global digital-dentistry market was valued at about $6.8 billion in 2025 and is projected to reach $17.9 billion by 2033, with Asia-Pacific expected to grow fastest, so the company is building capacity into a rising tide.
- USFDA registration underway - the company has completed formalities to register its 3D resins with the USFDA, which would unlock the large North American market where digital workflows are already mainstream.
3. Endodontic systems: the file that drills into a niche
A range of nickel-titanium rotary files for root-canal shaping, anchored by the Rotoflex brand, that turns a consumable into a system sale.
- Repeat demand validates the product - the Rotoflex endodontic file system has seen increasing reorders from clinicians, which in a procedure-driven category signals that the files perform reliably in real clinical use.
- Backed by specialist society ties - the company has partnered with the Indian Endodontic Society for education and research, giving the brand credibility with the specialists who influence file adoption.
4. Disinfectants and hygiene: a new vertical in a new building
Infection-control products for dental and medical settings, manufactured in a dedicated 16,000-square-foot facility commissioned alongside the main plant.
- Built for a post-pandemic need - the product line includes surface disinfectants, wipes, and hand-hygiene solutions under the ViroZym and ViroShield labels, targeting the same dental clinics and hospitals that already buy the company’s consumables.
- Early demand is encouraging - initial customer response after the FY26 launch has been strong, though the vertical is still ramping up and was delayed earlier by regulatory clearances.
5. Oradox oral care: the consumer shelf experiment
A branded range of toothpastes, mouthwashes, and oral-care gels that takes the company beyond the dental clinic and into retail.
- Same science, different buyer - the Oradox line leverages the company’s formulation know-how but targets consumers rather than dentists, representing a B2C channel alongside the core B2B business.
- Still a seedling - as of FY25, the brand had not yet made a meaningful revenue contribution, so it remains an early-stage initiative within the broader portfolio.
Group structure and partners
A debt-free promoter-led company with three young subsidiaries - one for marketing in India, one for US market entry, and one for the Middle East - plus research partnerships that feed the product pipeline.
- Denvisio Biomed Limited - incorporated in May 2023 and based in Gurugram, this wholly owned subsidiary handles marketing, digital campaigns, and brand-building for both domestic and international markets, freeing the parent to focus on manufacturing and R&D.
- Axiodent (USA) - a Delaware subsidiary set up in February 2025 to manage FDA registrations, local distribution, customer service, and brand visibility at US dental events; it has already begun contributing with initial orders and private-label work.
- Prevest Denpro Gulf (UAE) - a wholly owned subsidiary established in 2025 to strengthen Middle East presence, though commercial operations were delayed by regional geopolitical tensions; the board approved up to AED 500,000 in investment in May 2026.
- Research partnerships with teeth - a five-year MoU with the Indian Dental Association covers clinical education; separate agreements with IIT Kanpur (biomaterials for dental and orthopaedic use) and Sree Chitra Tirunal Institute (bioactive bone cement) give the company access to institutional science it does not have to build from scratch.